Diarylalkanes for Novel Applications
Legal Citation
Summary of the Inventive Concept
Expanding the scope of diarylalkanes as potent inhibitors of binuclear enzymes to tackle pressing issues in agriculture, environmental sustainability, corrosion prevention, water purification, and fuel efficiency.
Background and Problem Solved
The original patent disclosed diarylalkanes as inhibitors of binuclear enzymes for treating skin pigmentation. However, the potential of diarylalkanes extends beyond this application. The new inventive concept addresses the limitations of the original patent by exploring diarylalkanes' inhibitory effects in various industries, solving problems such as crop yield reduction, environmental pollution, metal corrosion, water contamination, and fuel inefficiency.
Detailed Description of the Inventive Concept
The new inventive concept leverages the core technology of diarylalkanes as potent inhibitors of binuclear enzymes to develop novel applications. Specifically, diarylalkane-based compositions can be applied to soil to inhibit binuclear enzymes that degrade plant nutrients, thereby improving agricultural crop yields. Additionally, diarylalkane-based compositions can treat industrial waste to reduce environmental pollutants, inhibit corrosion in metal surfaces, detect and remove heavy metals from water sources, and improve fuel efficiency in vehicles by treating fuel with diarylalkane-based additives.
Novelty and Inventive Step
The new claims introduce novel and non-obvious applications of diarylalkanes, expanding their use beyond skin pigmentation treatment. The inventive step lies in recognizing the potential of diarylalkanes to address diverse problems across various industries, thereby creating new opportunities for innovation and commercialization.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include using diarylalkanes as biopesticides, developing diarylalkane-based coatings for metal surfaces, or creating diarylalkane-infused fuel additives. Variations could involve modifying the diarylalkane structure to enhance its inhibitory effects or combining diarylalkanes with other compounds to create synergistic effects.
Potential Commercial Applications and Market
The new inventive concept has significant commercial potential across multiple industries, including agriculture, environmental sustainability, corrosion prevention, water purification, and fuel efficiency. The target market includes companies and organizations operating in these industries, as well as government agencies and research institutions seeking innovative solutions to pressing problems.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K8/347 |
| A | A61 | A61K8/31 |
| A | A61 | A61K8/4973 |
| A | A61 | A61K8/9789 |
| A | A61 | A61K8/9794 |
| A | A61 | A61K31/015 |
| A | A61 | A61K31/05 |
| A | A61 | A61K31/085 |
| A | A61 | A61K31/09 |
| A | A61 | A61K31/357 |
| A | A61 | A61K31/40 |
| A | A61 | A61K31/704 |
| A | A61 | A61Q19/02 |
| C | C07 | C07C39/15 |
| C | C07 | C07C39/367 |
| C | C07 | C07C41/26 |
| C | C07 | C07C41/32 |
| C | C07 | C07C43/23 |
| C | C07 | C07C45/673 |
| C | C07 | C07C49/835 |
| C | C07 | C07C215/74 |
| C | C07 | C07D321/12 |
| A | A61 | A61K2800/782 |
| Y | Y02 | Y02A50/30 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical and chemical engineering, with expertise in enzyme inhibition, molecular design, and biotechnological applications spanning medicinal chemistry, agricultural science, and materials engineering
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degree (MS/PhD) in chemistry, biochemistry, or chemical engineering, possessing knowledge of enzyme mechanisms, molecular structure-function relationships, and interdisciplinary problem-solving skills
Obviousness Rationale
Given the source patent's comprehensive disclosure of diarylalkanes as potent enzyme inhibitors with demonstrated biological activity, a PHOSITA would recognize the inherent potential to extend these compounds' utility across multiple technical domains. The fundamental mechanism of binuclear enzyme inhibition disclosed in the original patent provides a clear conceptual framework for exploring alternative applications. The PTD's variations represent predictable extrapolations of the core technological principle, utilizing known structure-activity relationships and established techniques for expanding molecular applications.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,657 |
|---|---|
| Title | Diarylalkanes as potent inhibitors of binuclear enzymes |
| Assignee(s) | Unigen, Inc. |